US$ 26.08
glp 1 drugs and breast cancer GLP-1 Cancer: Science, Safety, and Solutions Study links GLP-1 drugs to
Description
PloS One 8 (2), e55382

This was not a new idea

The MHRA and FDA have not flagged any contraindication between creatine and semaglutide or any other GLP-1 receptor agonist

The most commonly reported AE with tirzepatide were gastrointestinal, including nausea, diarrhoea and vomiting

Xiang J, Ding XY, Zhang W, Zhang J, Zhang YS, Li ZM, et al

The importance of GLP-1 is demonstrated in experiments showing that it accounts for up to 60% of postprandial insulin secretion in healthy individuals
